Omniose
PrivateLast Round
Grant
Sep 27, 2023
Total Funding Raised
$12.7M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Omniose is a biotechnology company that develops polysaccharide conjugate vaccines against bacterial threats using its proprietary bioconjugation platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Omniose Comparables
Compare Omniose with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| LimmaTech Biologics | 88% | |
| Glycovax Pharma | 81% | |
| Baxiva AG | 78% |
Omniose Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 27, 2023 | ||||
| Grant | Oct 11, 2022 | ||||
| Grant | Aug 20, 2020 | ||||
| Grant | Feb 21, 2020 | ||||
| Seed | Jan 1, 2019 | ||||
Grant | Nov 3, 2017 |
Key People
Founding team and executive leadership
Omniose Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Allergy and Infectious Diseases | Grant |
| Arch Grants | Grant |
| NIH RADx | Grant |
| BioGenerator Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 115% MoM, from 1.4K to 3.1K.
- Sep 27, 2023
$3M raised from National Institute of Allergy and Infectious Diseases
Omniose Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Omniose's valuation, stock price, and market status.
Is Omniose a public or private company?
Omniose is a private company.
What is the current stock price of Omniose?
Omniose is a private company with no public stock price. No recent secondary market data is available.
How much is Omniose worth (valuation)?
Valuation information for Omniose is not publicly available.
Can I buy Omniose stock?
Omniose shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Omniose's last funding round?
Omniose's most recent funding round was Grant on September 27, 2023.
Who are the main investors in Omniose?
Key investors in Omniose include National Institute of Allergy and Infectious Diseases, Arch Grants, NIH RADx, BioGenerator Ventures.
Will Omniose IPO soon?
No public IPO plans have been announced for Omniose.
How can I track Omniose secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Omniose's secondary market activity and sign up for updates.